INDICATION: Liver disease
Cell culture and mouse studies suggest liver-targeted TGFBR1 gene therapy could help treat Alagille syndrome, a genetic disease that affects the liver, bile duct and other tissues. In a mouse model of Alagille syndrome, TGFBR1 encoded in a liver-tropic adeno-associated viral (AAV)...